For someone struggling with weight management, these biological changes can significantly reduce food noise and help support long-term weight loss goals
DOSING USED IN PHASE 3 STUDIES In the most recent studies from the TRIUMPH programme (Phase 3) , retatrutide was administered as follows: Route: Subcutaneous Frequency: Once weekly Study duration: Approximately 68 weeks Recommended Dosage (Clinical Research Escalation Model) Retatrutide is administered once weekly using a gradual dose escalation to improve tolerability
It can also break down muscle tissue if protein intake is insufficient
It's sterile water that contains 0.9% benzyl alcohol, which acts as a preservative to prevent bacterial growth after the vial's rubber stopper has been punctured
Over time, this changes your usual habits and can support steady weight loss, especially when paired with daily movement
Tirzepatide: FDA 2022, EMA 2022